312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • iBIO Connect
  • Contact Us
iBIO
  • About
    • Introduction
    • Leadership
    • Contact
  • PROGRAMS
    • Overview
    • LabShare
    • STEMKits
    • StellarGirls
    • BioGENEius Illinois
  • Advocacy
    • Overview
    • Advocacy Center
    • Advocacy Toolkit
    • Rare Disease
  • News & Events
    • News
    • Events
    • Daily Newsletter
    • Walbert Award
  • Member Resources
    • Member Benefits
    • Business Solutions
    • Member Committees
    • Join iBIO
      • Discover our Community
  • Illinois Industry
    • About Illinois
    • Resource Map
    • State Incentives
Select Page
CLP Spinout Rounds Third Base with New Treatment for Metastatic Cancers and Fibrosis

CLP Spinout Rounds Third Base with New Treatment for Metastatic Cancers and Fibrosis

by John Conrad | Dec 4, 2019 | Member News

Veteran entrepreneurs and cofounders of Actuate Therapeutics, Inc., Daniel Schmitt and Andrew Mazar, PhD, are taking no chances with their lead clinical candidate 9-ING-41, a promising new treatment for advanced and drug-resistant cancers and select inflammatory...
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X